Skip to main content

GeneDx to Participate in Upcoming Investor Conferences

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June:

  • Jefferies Healthcare Conference - New York City, New York
    Fireside chat on Wednesday, June 5 at 9:00 a.m. ET
  • 44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida
    Fireside chat on Monday, June 10 at 3:20 p.m. ET

Live and archived webcasts of the presentation will be available on the “Events” section of the GeneDx investor relations website at

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit and connect with us on LinkedIn, X, Facebook, and Instagram.

Investor Relations Contact:

Media Contact:


Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.